ORCID as entered in ROS

Select Publications
2022, 'Consensus for experimental design in electromyography (CEDE) project: High-density surface electromyography matrix', Journal of Electromyography and Kinesiology, 64, pp. 102656, http://dx.doi.org/10.1016/j.jelekin.2022.102656
,2022, 'Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis', Brain, 145, pp. 1598 - 1609, http://dx.doi.org/10.1093/brain/awac077
,2022, 'Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis', Lancet Neurology, 21, pp. 465 - 479, http://dx.doi.org/10.1016/S1474-4422(21)00414-2
,2022, 'Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis', Lancet Neurology, 21, pp. 480 - 493, http://dx.doi.org/10.1016/S1474-4422(21)00465-8
,2022, 'Differences in nerve excitability properties across upper limb sensory and motor axons', Clinical Neurophysiology, 136, pp. 138 - 149, http://dx.doi.org/10.1016/j.clinph.2021.12.006
,2022, 'Neuronal Hyperexcitability and Free Radical Toxicity in Amyotrophic Lateral Sclerosis: Established and Future Targets', Pharmaceuticals, 15, http://dx.doi.org/10.3390/ph15040433
,2022, 'The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors', Journal of Cancer Survivorship, 16, pp. 223 - 232, http://dx.doi.org/10.1007/s11764-021-01012-y
,2022, 'The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis', Brain, 145, pp. 1207 - 1210, http://dx.doi.org/10.1093/brain/awab472
,2022, 'Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis', Neuron, 110, pp. 992 - 1008.e11, http://dx.doi.org/10.1016/j.neuron.2021.12.019
,2022, 'A robust framework for characterising diffusion metrics of the median and ulnar nerves: Exploiting state-of-the-art tracking methods', Journal of the Peripheral Nervous System, 27, pp. 67 - 83, http://dx.doi.org/10.1111/jns.12478
,2022, 'Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1)', Nature Genetics, 54, pp. 361 - 361, http://dx.doi.org/10.1038/s41588-022-01020-3
,2022, 'Thalamic and Cerebellar Regional Involvement across the ALS–FTD Spectrum and the Effect of C9orf72', Brain Sciences, 12, http://dx.doi.org/10.3390/brainsci12030336
,2022, 'Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS', Science Translational Medicine, 14, http://dx.doi.org/10.1126/scitranslmed.abj0264
,2022, 'Ocular involvement of acanthosis nigricans', ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, http://dx.doi.org/10.1080/01676830.2021.2014894
,2022, 'Mantle cell lymphoma presenting as bilateral upper eyelid entropion', ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, http://dx.doi.org/10.1080/01676830.2022.2025858
,2022, 'A Compound Heterozygous Mutation in Calpain 1 Identifies a New Genetic Cause for Spinal Muscular Atrophy Type 4 (SMA4)', Frontiers in Genetics, 12, http://dx.doi.org/10.3389/fgene.2021.801253
,2022, 'Sleep apnea phenotyping and relationship to disease in a large clinical biobank', JAMIA OPEN, 5, http://dx.doi.org/10.1093/jamiaopen/ooab117
,2022, 'MiNDAUS partnership: a roadmap for the cure and management of motor Neurone disease', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 23, pp. 321 - 328, http://dx.doi.org/10.1080/21678421.2021.1980889
,2022, 'Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis', Journal of Neurology Neurosurgery and Psychiatry, 93, pp. 668 - 678, http://dx.doi.org/10.1136/jnnp-2021-327909
,2022, 'Posturography as a biomarker of intravenous immunoglobulin efficacy in chronic inflammatory demyelinating polyradiculoneuropathy', Muscle and Nerve, 65, pp. 43 - 50, http://dx.doi.org/10.1002/mus.27398
,2022, 'Progress, development, and challenges in amyotrophic lateral sclerosis clinical trials', Expert Review of Neurotherapeutics, 22, pp. 905 - 913, http://dx.doi.org/10.1080/14737175.2022.2161893
,2022, 'TH-265. Evidence of sensory and fine motor dysfunction in peripheral and central nervous systems in Kennedy’s disease (KD)', Clinical Neurophysiology, 141, pp. S171 - S171, http://dx.doi.org/10.1016/j.clinph.2022.07.451
,2022, 'Two ophthalmic presentations of chronic myeloid leukaemia', EJHAEM, 3, pp. 1064 - 1065, http://dx.doi.org/10.1002/jha2.461
,2021, 'Apathy is associated with parietal cortical-subcortical dysfunction in ALS', Cortex, 145, pp. 341 - 349, http://dx.doi.org/10.1016/j.cortex.2021.02.029
,2021, 'Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology', Nature Genetics, 53, pp. 1636 - 1648, http://dx.doi.org/10.1038/s41588-021-00973-1
,2021, 'Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis', Neuropathology and Applied Neurobiology, 47, pp. 979 - 989, http://dx.doi.org/10.1111/nan.12709
,2021, 'Motor cortical excitability predicts cognitive phenotypes in amyotrophic lateral sclerosis', Scientific Reports, 11, http://dx.doi.org/10.1038/s41598-021-81612-x
,2021, 'Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia', Communications Medicine, 1, http://dx.doi.org/10.1038/s43856-021-00060-w
,2021, 'The end of the affair?', Journal of Neurology Neurosurgery and Psychiatry, 92, pp. 1249 - 1250, http://dx.doi.org/10.1136/jnnp-2021-328176
,2021, 'Factors That Influence Non-Motor Impairment Across the ALS-FTD Spectrum: Impact of Phenotype, Sex, Age, Onset and Disease Stage', Frontiers in Neurology, 12, http://dx.doi.org/10.3389/fneur.2021.743688
,2021, 'Gold Coast diagnostic criteria: Implications for ALS diagnosis and clinical trial enrollment', Muscle and Nerve, 64, pp. 532 - 537, http://dx.doi.org/10.1002/mus.27392
,2021, 'Nerve biopsy in acquired neuropathies', Journal of the Peripheral Nervous System, 26, pp. S21 - S41, http://dx.doi.org/10.1111/jns.12464
,2021, 'Chemotherapy and peripheral neuropathy', Neurological Sciences, 42, pp. 4109 - 4121, http://dx.doi.org/10.1007/s10072-021-05576-6
,2021, 'Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia', Clinical Neurophysiology, 132, pp. 2568 - 2607, http://dx.doi.org/10.1016/j.clinph.2021.05.035
,2021, 'Safety and efficacy of dimethyl fumarate in ALS: randomised controlled study', Annals of Clinical and Translational Neurology, 8, pp. 1991 - 1999, http://dx.doi.org/10.1002/acn3.51446
,2021, 'Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial', Lancet Neurology, 20, pp. 821 - 831, http://dx.doi.org/10.1016/S1474-4422(21)00242-8
,2021, 'Illness Cognitions in ALS: New Insights Into Clinical Management of Behavioural Symptoms', Frontiers in Neurology, 12, http://dx.doi.org/10.3389/fneur.2021.740693
,2021, 'Effect of hemodiafiltration on the progression of neuropathy with kidney failure: A randomized controlled trial', Clinical Journal of the American Society of Nephrology, 16, pp. 1365 - 1375, http://dx.doi.org/10.2215/CJN.17151120
,2021, 'Effect of racial background on motor cortical function as measured by threshold tracking transcranial magnetic stimulation', Journal of Neurophysiology, 126, pp. 840 - 844, http://dx.doi.org/10.1152/jn.00083.2021
,2021, 'Cortical hyperexcitability: Diagnostic and pathogenic biomarker of ALS', Neuroscience Letters, 759, http://dx.doi.org/10.1016/j.neulet.2021.136039
,2021, 'Consensus for experimental design in electromyography (CEDE) project: Terminology matrix', Journal of Electromyography and Kinesiology, 59, pp. 102565, http://dx.doi.org/10.1016/j.jelekin.2021.102565
,2021, 'Nerve biopsy: Current indications and decision tools', Muscle and Nerve, 64, pp. 125 - 139, http://dx.doi.org/10.1002/mus.27201
,2021, 'Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS-FTD spectrum', Annals of Clinical and Translational Neurology, 8, pp. 1576 - 1591, http://dx.doi.org/10.1002/acn3.51363
,2021, 'Neurology and clinical neurophysiology: An artificial divide', Practical Neurology, 21, pp. 274 - 275, http://dx.doi.org/10.1136/practneurol-2021-002946
,2021, 'Brainstem Correlates of Pathological Laughter and Crying Frequency in ALS', Frontiers in Neurology, 12, http://dx.doi.org/10.3389/fneur.2021.704059
,2021, 'Coexisting Lewy body disease and clinical parkinsonism in amyotrophic lateral sclerosis', European Journal of Neurology, 28, pp. 2192 - 2199, http://dx.doi.org/10.1111/ene.14849
,2021, 'Genetic Analysis of Tryptophan Metabolism Genes in Sporadic Amyotrophic Lateral Sclerosis', Frontiers in Immunology, 12, http://dx.doi.org/10.3389/fimmu.2021.701550
,2021, 'Author Response: Phenotypic Variability in ALS-FTD and Effect on Survival', Neurology, 96, pp. 1103 - 1104, http://dx.doi.org/10.1212/WNL.0000000000012073
,2021, 'Behavioural changes predict poorer survival in amyotrophic lateral sclerosis', Brain and Cognition, 150, http://dx.doi.org/10.1016/j.bandc.2021.105710
,2021, 'Neural correlates of fat preference in frontotemporal dementia: translating insights from the obesity literature', Annals of Clinical and Translational Neurology, 8, pp. 1318 - 1329, http://dx.doi.org/10.1002/acn3.51369
,